CAS: 6090-95-5; Rel-(1R,2R,3S,4S,5R,6S)-7-Oxabicyclo[4.1.0]Heptane-2,3,4,5-Tetraol

相似化合物

6705-49-3 106-86-5 133319-97-8

上下游产品

CAS号110550-28-2 (+)-(1S,2R,3S,4... | CAS号138258-55-6 (+/-) conduritol B | CAS号4381-96-8 (+/-)-(1,3/2,4)... | CAS号40617-60-5 1,2：5,6-双-O-(1-... | CAS号120710-66-9 (±)-1,6-di-O-be... | CAS号120679-73-4 (+/-)-3,4-di-O-... | CAS号85798-11-4 (4S,5R,6S)-4,5,... | CAS号102997-58-0 conduritol B

专利信息

专利号:WO-2023008461-A1
优先权日:2021-07-27
标题:Medicament for treatment and/or prevention of cancer
发明人：KUME MASAHIKO; OKANO FUMIYOSHI; SAITO TAKANORI
权利人:TORAY INDUSTRIES
摘要:The present invention relates to a medicament for the treatment and/or prevention of cancer, the medicament being characterized by comprising an antibody having an immunological reactivity with CAPRIN-1 protein or a fragment of the antibody and a drug capable of inhibiting the N-glycoside-linked sugar chain synthesis of a glycoprotein which are combined with each other in a blended or separated form.

专利号:US-2010151526-A1
优先权日:2005-09-22
标 题 :Method of Producing Sucrose-6-Acetate by Whole-Cell Biocatalysis
发明人：RATNAM RAKESH; AURORA SUNDEEP; SUBRAMANIYAM P
权利人:PHARMED MEDICARE PVT LTD
摘要:A process is described which uses whole cell preparations, immobilized or without immobilization, of a microorganism, including Aureobasidium pullulans , capable of forming enzymes of the group of fructosyltransferases, for catalyzing a reaction between sucrose and 6-O-protected glucose for formation of 6-O-protected sucrose, an intermediate in synthesis of trichlorogalactosucrose. 6-O-protected Sucrose is separated from high molecular weight by-products of the reaction having molecular weight of 500 daltons and more by reverse osmosis, and further purified by column chromatography.

专利号:US-7429460-B2
优先权日:2003-01-15
标 题 :Methods of screening for inhibitors of phospholipid synthesis related to glycolipid-storage diseases
发明人：FUTERMAN ANTHONY H; BODENNEC JACQUES; PELLED DORI
权利人:YEDA RES & DEV
摘要:The present invention discloses methods of screening for identification of compounds that inhibit novel targets in the enzymatic pathway of phospholipid synthesis that are related to glycolipid storage diseases, and use of the compounds for treating patients affected with glycolipid storage diseases, particularly Gaucher disease. Specifically, the compounds of the present invention are intended to inhibit the accumulation of phosphatidylcholine (PC), wherein PC accumulation is increased due to the activation of CTP:phosphocholine cytidylyltransferase (CCT) upon glucosylceramide (GlcCer) accumulation.

专利号:CN-118165950-A
优先权日:2024-03-18
标 题:Application of laminaria oligosaccharide phosphorylase in synthesis of laminaria oligosaccharide and multienzyme catalytic system

专利号:US-6562606-B1
优先权日:1993-03-19
标 题:Methods and compositions for disrupting the epithelial barrier function
发明人：ELIAS PETER M; FEINGOLD KENNETH R; HOLLERAN WALTER M
权利人:UNIV CALIFORNIA; CELLEGY PHARMA INC
摘要:A method for disrupting epithelial barrier function in a host in need of the topical administration of a physiologically active substance which comprises applying to the epithelium of the host, barrier-disrupting amount of at least one agent selected from the group consisting of an inhibitor of ceramide synthesis, inhibitor of acylceramide synthesis, inhibitor of glucosylceramide synthesis, and inhibitor of sphingomyelin synthesis, an inhibitor of fatty acid synthesis, an inhibitor of cholesterol synthesis, a degradation enzyme of ceramides, acylceramide, glucosylceramides, sphingomyelin, an inhibitor of phospholipid, glycosphingolipid, including glucosylceramide, acylceramide or sphingomyelin degradation, and both inhibitors and stimulators of metabolic enzymes of free fatty acids, ceramide, and cholesterol, as well as a topical composition useful therefor are disclosed.

专利号:US-2004137531-A1
优先权日:2003-01-15
标题 :Methods of screening for inhibitors of phospholipid synthesis related to glycolipid-storage diseases